12
Views
1
CrossRef citations to date
0
Altmetric
Review

Preventing, identifying and managing thyroid deficiency in prenatal practice

Pages 213-222 | Published online: 10 Jan 2014

References

  • ACOG Committee. Opinion No. 381. Subclinical hypothyroidism in pregnancy. Obstet. Gynecol. 110(4), 959–960 (2007).
  • Stagnaro-Green A, Abalovich M, Alexander E et al.; American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21(10), 1081–1125 (2011).
  • De Groot L, Abalovich M, Alexander EK et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 97(8), 2543–2565 (2012).
  • Hollowell JG, Haddow JE. The prevalence of iodine deficiency in women of reproductive age in the United States of America. Public Health Nutr. 10(12A), 1532–1539; discussion 1540 (2007).
  • Leung AM, Pearce EN, Braverman LE. Sufficient iodine intake during pregnancy: just do it. Thyroid 23(1), 7–8 (2013).
  • Stagnaro-Green A, Sullivan S, Pearce EN. Iodine supplementation during pregnancy and lactation. JAMA 308(23), 2463–2464 (2012).
  • Andersen S, Pedersen KM, Pedersen IB, Laurberg P. Variations in urinary iodine excretion and thyroid function. A 1-year study in healthy men. Eur. J. Endocrinol. 144(5), 461–465 (2001).
  • Haddow JE, McClain MR, Palomaki GE, Hollowell JG. Urine iodine measurements, creatinine adjustment, and thyroid deficiency in an adult United States population. J. Clin. Endocrinol. Metab. 92(3), 1019–1022 (2007).
  • Caldwell KL, Makhmudov A, Ely E, Jones RL, Wang RY. Iodine status of the U.S. population, National Health and Nutrition Examination Survey, 2005–2006 and 2007–2008. Thyroid 21(4), 419–427 (2011).
  • WHO, United Nations Children’s Fund, and International Council for the Control of Iodine Deficiency Disorders. Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination: A Guide for Programme Managers (3rd Edition). WHO, Geneva, Switzerland (2007).
  • McClain MR, Lambert-Messerlian G, Haddow JE et al.; FaSTER Research Consortium. Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am. J. Obstet. Gynecol. 199(2), 129.e1–129.e6 (2008).
  • Medici M, Timmermans S, Visser W et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. J. Clin. Endocrinol. Metab. 98(1), 59–66 (2013).
  • Yassa L, Marqusee E, Fawcett R, Alexander EK. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J. Clin. Endocrinol. Metab. 95(7), 3234–3241 (2010).
  • Loh JA, Wartofsky L, Jonklaas J, Burman KD. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid 19(3), 269–275 (2009).
  • Vadiveloo T, Mires GJ, Donnan PT, Leese GP. Thyroid testing in pregnant women with thyroid dysfunction in Tayside, Scotland: the thyroid epidemiology, audit and research study (TEARS). Clin. Endocrinol. (Oxf.) 78(3), 466–471 (2013).
  • Vaidya B. Management of hypothyroidism in pregnancy: we must do better. Clin. Endocrinol. (Oxf.) 78(3), 342–343 (2013).
  • Lambert-Messerlian G, McClain M, Haddow JE et al.; FaSTER Research Consortium. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (first- and second-trimester evaluation of risk for aneuploidy) Research Consortium study. Am. J. Obstet. Gynecol. 199(1), 62.e1–62.e6 (2008).
  • Haddow JE, McClain MR, Lambert-Messerlian G et al.; First and Second Trimester Evaluation of Risk for Fetal Aneuploidy Research Consortium. Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy. J. Clin. Endocrinol. Metab. 93(9), 3341–3347 (2008).
  • Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am. J. Obstet. Gynecol. 167(3), 648–652 (1992).
  • Tan JY, Loh KC, Yeo GS, Chee YC. Transient hyperthyroidism of hyperemesis gravidarum. BJOG 109(6), 683–688 (2002).
  • Fell DB, Dodds L, Joseph KS, Allen VM, Butler B. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet. Gynecol. 107(2 Pt 1), 277–284 (2006).
  • Bouillon R, Naesens M, Van Assche FA et al. Thyroid function in patients with hyperemesis gravidarum. Am. J. Obstet. Gynecol. 143(8), 922–926 (1982).
  • Kauppila A, Huhtaniemi I, Ylikorkala O. Raised serum human chorionic gonadotrophin concentrations in hyperemesis gravidarum. Br. Med. J. 1(6179), 1670–1671 (1979).
  • Depue RH, Bernstein L, Ross RK, Judd HL, Henderson BE. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am. J. Obstet. Gynecol. 156(5), 1137–1141 (1987).
  • Vaidya B, Anthony S, Bilous M et al. Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding? J. Clin. Endocrinol. Metab. 92(1), 203–207 (2007).
  • Haddow JE, McClain MR, Palomaki GE, Kloza EM, Williams J. Screening for thyroid disorders during pregnancy: results of a survey in Maine. Am. J. Obstet. Gynecol. 194(2), 471–474 (2006).
  • Chang DL, Leung AM, Braverman LE, Pearce EN. Thyroid testing during pregnancy at an academic Boston Area Medical Center. J. Clin. Endocrinol. Metab. 96(9), E1452–E1456 (2011).
  • Blatt AJ, Nakamoto JM, Kaufman HW. National status of testing for hypothyroidism during pregnancy and postpartum. J. Clin. Endocrinol. Metab. 97(3), 777–784 (2012).
  • Toulis KA, Goulis DG, Venetis CA et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur. J. Endocrinol. 162(4), 643–652 (2010).
  • Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur. J. Endocrinol. 150(6), 751–755 (2004).
  • Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264(11), 1422–1425 (1990).
  • Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J. Clin. Endocrinol. Metab. 91(7), 2587–2591 (2006).
  • Negro R, Mangieri T, Coppola L et al. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum. Reprod. 20(6), 1529–1533 (2005).
  • Tan TO, Cheng YW, Caughey AB. Are women who are treated for hypothyroidism at risk for pregnancy complications? Am. J. Obstet. Gynecol. 194(5), e1–e3 (2006).
  • Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Obstetric and neonatal outcomes associated with maternal hypothyroid disease. J. Matern. Fetal. Neonatal. Med. 17(1), 35–38 (2005).
  • Casey BM, Dashe JS, Wells CE et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol. 105(2), 239–245 (2005).
  • Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ. Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur. J. Endocrinol. 160(6), 985–991 (2009).
  • Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J. Clin. Endocrinol. Metab. 95(9), E44–E48 (2010).
  • Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH. Maternal thyroid function at 11–13 weeks of gestation and spontaneous preterm delivery. Obstet. Gynecol. 117(2 Pt 1), 293–298 (2011).
  • Cleary-Goldman J, Malone FD, Lambert-Messerlian G et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet. Gynecol. 112(1), 85–92 (2008).
  • Männistö T, Vääräsmäki M, Pouta A et al. Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J. Clin. Endocrinol. Metab. 94(3), 772–779 (2009).
  • Lazarus JH, Bestwick JP, Channon S et al. Antenatal thyroid screening and childhood cognitive function. N. Engl. J. Med. 366(6), 493–501 (2012).
  • Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 12(1), 63–68 (2002).
  • Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstet. Gynecol. 81(3), 349–353 (1993).
  • Allan WC, Haddow JE, Palomaki GE et al. Maternal thyroid deficiency and pregnancy complications: implications for population screening. J. Med. Screen. 7(3), 127–130 (2000).
  • Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341(8), 549–555 (1999).
  • Abu-Helalah M, Law MR, Bestwick JP, Monson JP, Wald NJ. A randomized double-blind crossover trial to investigate the efficacy of screening for adult hypothyroidism. J. Med. Screen. 17(4), 164–169 (2010).
  • Haddow JE, Craig WY, Palomaki GE et al. Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy. Thyroid 23(2), 225–230 (2013).
  • Lee RH, Spencer CA, Mestman JH et al. Free T4 immunoassays are flawed during pregnancy. Am. J. Obstet. Gynecol. 200(3), 260.e1–260.e6 (2009).
  • Soldin OP, Hilakivi-Clarke L, Weiderpass E, Soldin SJ. Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays. Clin. Chim. Acta 349(1–2), 181–189 (2004).
  • Toft AD, Beckett GJ. Measuring serum thyrotropin and thyroid hormone and assessing thyroid hormone transport. In: Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text. Braverman LE, Utiger RD (Eds). Lippincott, Williams & Wilkins, PA, USA, 329–344 (2005).
  • Soldin OP, Soldin SJ. Thyroid hormone testing by tandem mass spectrometry. Clin. Biochem. 44(1), 89–94 (2011).
  • Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J. Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid 17(4), 303–311 (2007).
  • Smallridge RC. Postpartum thyroid disease: a model of immunologic dysfunction. Clin. Appl. Immunol. Rev. 1(2), 89–103 (2000).
  • Stagnaro-Green A. Clinical review 152: postpartum thyroiditis. J. Clin. Endocrinol. Metab. 87(9), 4042–4047 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.